Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.
Offering the potential benefits of streamlined scanning and intelligent automation in magnetic resonance imaging (MRI), GE Healthcare recently launched the SIGNA Experience, which combines imaging software, artificial intelligence (AI) applications and automated workflow technologies into one platform.
GE Healthcare said the four primary components of the SIGNA Experience include enhanced image quality through the next-generation imaging software SIGNA One (available on SIGNA Prime); deep learning AI applications (including AIR Recon DL) that facilitate shorter scan times and improved signal-to-noise (SNR) ratios; flexible, lightweight AIR Coils; and automated workflow technologies, such as AIRTouch, that simplify scan set-up.
The SIGNA Experience also offers visually highlighted fields for step-by-step guidance, minimal clicks to complete the MRI exam and an intuitive workflow that accommodates a variety of experience levels, according to GE Healthcare.
“SIGNA Experience was designed in response to today’s industry pressures to help achieve operational efficiency and simplicity as clinicians face a significant volume of non-urgent backlog scans caused largely by the impact of COVID-19, radiologist shortages and staff burnout,” explained Jie Xue, the president, and CEO of Magnetic Resonance for GE Healthcare. “These technologies enable scanner operators of all skill levels to get the job done without compromising quality and output.”
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.